Congratulations to Ross Wilson in our Molecular Therapeutics Division in MCB at @UCBerkeley for delivering his promotion talk! Ross is developing new CRISPR delivery methods, spearheading our hands-on therapeutics discovery lab for undergrads, and founding Editpep!
Hi all! great @KeystoneSymp meeting on Ubiquitin coming up, poster deadline fast approaching (2/2/26). Held at some place and time as Induced Proximity meeting. Hope to see you there!
#LungCancerAwarenessMonth reminds us why our mission matters, innovation saves lives. Our novel CBL-B inhibitor NX-1607 aims to deliver new hope and improved outcomes for people affected by solid tumors including #lungcancer.
Learn more about our work: https://t.co/rPY8f0ohU5
Nurix’s CSO, Gwenn Hansen, Ph.D., will discuss the development of novel BTK degrader bexobrutideg (NX-5948) in a presentation at the 8th Annual TPD & Induced Proximity Summit on Tues, Oct 28, 2025, at 12:15 a.m. ET.
Learn more here:
https://t.co/tP9mEEN7xP
#TPDSummit2025
Excited that our study identifying TRIP12 - an essential E3 ligase mutated in a neurodevelopmental disease - as a critical component of the oxidative stress response is now online. Congratulations to Andrew, Devlon and Jenny! @berkeleyMCB@UCBerkeley
https://t.co/yto3iq8lDz
Check out the Stanford.Berkeley.UCSF Next Generation Faculty Symposium highlighting the work of exceptional early-career scientists in the broad field of quantitative biological and biomedical sciences:
Wednesday, Sept. 10th 2025 9:30AM - 1:45PM (PT):
https://t.co/VGR1raVWe1
🔬 The Future of Biotech is Female… and It’s Global.
We just wrapped a strategic advisory with international female founders in life sciences; winners of the @dwih_sf sponsored 8-week entrepreneurship program hosted by The GUILD.
They’re innovating across cancer, clinical trials, and sustainability, and they came to the Bay Area ready to scale 🌉
#WomenInSTEM #MolecularTherapeutics #DWIH #TheGUILD #BiotechFounders #MTI #MolecularTherapeuticsInitiative
Really cool first #MolecularTherapeutics seminar of the season by Damian Young of Baylor College of Medicine! What a cool combination of biology and cutting-edge chemistry!!! Thank you for visiting us! @MTI_UCB@UCBerkeley@berkeleyMCB
Inspiring day at the @berkeleyMCB Molecular Therapeutics Division retreat at Bakar BioEnginuity Hub! Grateful to our trainees for sharing their research and to keynote Kevin Eggan (CSO at BioMarin) for insights into translating basic science into life-changing therapeutics.
Today on #WorldCLLDay, we join the global community in raising awareness of #CLL. At $NRIX, we’re advancing bexobrutideg (NX-5948), our BTK degrader, with the goal of transforming outcomes and bringing new hope to patients. Learn more about #CLL here: https://t.co/PKvVU7aMew
Check out this recap of Berkeley's recent inaugural Bay Area Biotech Day which brought communities together to foster collaboration & accelerate the translation of cutting-edge biological discoveries into life-changing therapeutics! 🧪 @MTI_UCB
https://t.co/opkHN7HIOr
Tenure track position alert! Assistant Professor of Molecular Therapeutics in MCB @UCBerkeley. Apply and come be our colleague! 🎉
https://t.co/AoeWrtlzgb
Excited about turning basic science into new therapeutic modalities? Want to work with brilliant and *friendly* colleagues? Hoping to be part of a public university that shapes California? Then come join us #MolecularTherapeutics@MTI_UCB@berkeleyMCB !!!